Silence Therapeutics (SLN) Short-Term Debt repayments (2020 - 2024)
Silence Therapeutics' Short-Term Debt repayments history spans 5 years, with the latest figure at -$63665.7 for Q3 2024.
- On a quarterly basis, Short-Term Debt repayments fell 2.57% to -$63665.7 in Q3 2024 year-over-year; TTM through Sep 2024 was -$226624.1, a 25.46% decrease, with the full-year FY2020 number at -$516226.8, changed N/A from a year prior.
- Short-Term Debt repayments hit -$63665.7 in Q3 2024 for Silence Therapeutics, down from -$62067.6 in the prior quarter.
- Over the last five years, Short-Term Debt repayments for SLN hit a ceiling of $559704.8 in Q3 2021 and a floor of -$701659.6 in Q2 2021.
- Historically, Short-Term Debt repayments has averaged -$76467.7 across 5 years, with a median of -$62965.7 in 2022.
- Biggest five-year swings in Short-Term Debt repayments: skyrocketed 91.03% in 2022 and later plummeted 251.1% in 2023.
- Tracing SLN's Short-Term Debt repayments over 5 years: stood at -$171658.6 in 2020, then skyrocketed by 426.06% to $559704.8 in 2021, then plummeted by 103.16% to -$17678.2 in 2022, then plummeted by 251.1% to -$62067.6 in 2023, then decreased by 2.57% to -$63665.7 in 2024.
- Business Quant data shows Short-Term Debt repayments for SLN at -$63665.7 in Q3 2024, -$62067.6 in Q3 2023, and -$42546.3 in Q2 2023.